ADMI welcomes the government's decision to maintain stringent clinical trial requirements for In-Vitro Diagnostics (IVDs), reinforcing the commitment to safety and efficacy in India’s healthcare sector. By refusing to waive clinical trials for IVDs approved in other developed countries, the government ensures that these devices
Indian healthcare industry is transforming at a stellar pace with the advent of new-age technologies and equipment. New-age technologies are not only helping extend healthcare to far-off corners of the country, but also improving accuracy and assisting with early diagnosis of diseases. Under the ‘Make in India’ initiative,
Medgate Today - India's largest healthcare magazine, in association with Medical Fair India - India No. 1 healthcare and Medical event, organised the Jury Committee Meeting of the annual MT India Awards 2021 of the 11th edition on 05th July 2021 through Zoom. Mr Afzal
